Brief: Eterna Therapeutics Received A Notice From Nasdaq Stating That Co Is Not In Compliance With Nasdaq Listing Rule 5550(B)(1)

Ernexa Therapeutics

22/03/2024 20:45

March 22 (Reuters) - Eterna Therapeutics Inc  ERNA.O :
    * ETERNA THERAPEUTICS INC -  ON MARCH 19, RECEIVED A NOTICE
FROM
NASDAQ STATING THAT CO IS NOT IN COMPLIANCE WITH NASDAQ LISTING
RULE 5550(B)(1)

Source text for Eikon: [ID:https://bitly.ws/3gB29]
Further company coverage:  ERNA.O 

 ((Reuters.Briefs@thomsonreuters.com;))